Cambridge Network

iXCells Biotechnologies reaches iPSC line delivery milestone in collaboration with global biotechnology company

PSCore platform delivered over 500 characterized iPSC lines during first year of collaboration . SAN DIEGO, CA, 11 March 2026 ...
Contract Pharma

iXCells Delivers 500+ Characterized iPSC Lines for Global Biotechnology Company

XCells Biotechnologies USA Inc. has delivered over 500 characterized induced pluripotent stem cell lines as part of a multi-year collaboration with a global biotechnology company.

Unixell Biotech receives IND clearance by FDA for its Allogeneic iPSC-Derived cell therapy, UX-GIP001, for focal Epilepsy

On March 12, Unixell Biotech achieved a significant milestone as UX-GIP001, its iPSC-derived allogeneic cell therapy targeting focal epilepsy, secured Investigational New Drug (IND) clearance from the ...
Technology Networks

What If Aging Were a Disease We Could Prevent?

Emerging research in cellular reprogramming, gene editing, and regenerative medicine is driving interest in preventive ...
Nature

Accelerating off-the-shelf cell therapies for inflammatory and autoimmune diseases with an end-to-end platform

Induced pluripotent stem cell technology is a promising, rapidly evolving field with the potential to transform cell-based therapeutics across a range of disease areas that have significant unmet ...